Pazopanib maintenance therapy after tandem high-dose chemotherapy for disseminated Ewing sarcoma-Reference-Cited by-同舟云学术

Pazopanib maintenance therapy after tandem high-dose chemotherapy for disseminated Ewing sarcoma

Published:2019-02-14 Issue:3 Volume:8 Page:95-100
ISSN:2192-3183
Container-title:International Cancer Conference Journal
language:en
Short-container-title:Int Canc Conf J

Author:

Tamura Akihiro^ORCID,Yamamoto Nobuyuki,Nino Nanako,Ichikawa Takayuki,Nakatani Naoko,Nakamura Sayaka,Saito Atsuro,Kozaki Aiko,Kishimoto Kenji,Ishida Toshiaki,Yoshida Makiko,Akasaka Yoshinobu,Hasegawa Daiichiro,Kosaka Yoshiyuki

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/article/10.1007/s13691-019-00362-w/fulltext.html

Reference15 articles.

1. Ladenstein R, Pötschger U, Le Deley MC et al (2010) Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial. J Clin Oncol 28:3284–3291

2. Gaspar N, Hawkins DS, Dirksen U et al (2015) Ewing sarcoma: current management and future approaches through collaboration. J Clin Oncol 33:3036–3046

3. Paulussen M, Ahrens S, Burdach S et al (1998) Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 9:275–281

4. Loschi S, Dufour C, Oberlin O et al (2015) Tandem high-dose chemotherapy strategy as first-line treatment of primary disseminated multifocal Ewing sarcomas in children, adolescents and young adults. Bone Marrow Transpl 50:1083–1088

5. Thiel U, Wawer A, von Luettichau I et al (2016) Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow. Oncotarget 7:70959–70968

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinicopathological and molecular genetic analysis of 13 cases of primary retroperitoneal Ewing sarcoma;Annals of Diagnostic Pathology;2024-10

2. Current status and future directions of systemic therapy in high-grade bone sarcomas;N.N. Priorov Journal of Traumatology and Orthopedics;2024-07-04

3. Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma;Oncoscience;2023-09-20

4. Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor Board;Cancer;2023-07-05

5. Recent advances on anti-angiogenic multi-receptor tyrosine kinase inhibitors in osteosarcoma and Ewing sarcoma;Frontiers in Oncology;2023-03-13